secwatch / observer
8-K filed February 11, 2025, 6:59 PM ET ticker KRRO CIK 0001703647
leadership confidence high sentiment neutral materiality 0.55

Korro Bio CFO Vineet Agarwal takes temporary medical leave; CEO Ram Aiyar named interim principal financial officer

Korro Bio, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Vineet Agarwal

Chief Financial Officer
KRRO · Korro Bio, Inc.
Effective
2025-02-11
Filed
February 11, 2025, 6:59 PM ET
Effective February 11, 2025, Vineet Agarwal, Chief Financial Officer (principal financial officer and principal accounting officer) of Korro Bio, Inc., or Korro, is taking a temporary medical leave of absence.
Appointed (interim)

Oliver Dolan

Interim Principal Accounting Officer
KRRO · Korro Bio, Inc.
Effective
2025-02-11
Successor
Vineet Agarwal
Filed
February 11, 2025, 6:59 PM ET
and Mr. Oliver Dolan, Senior Vice President, Finance, to serve as Korro’s interim principal accounting officer
Appointed (interim)

Ram Aiyar

Interim Principal Financial Officer
KRRO · Korro Bio, Inc.
Effective
2025-02-11
Successor
Vineet Agarwal
Filed
February 11, 2025, 6:59 PM ET
Korro’s Board of Directors appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro’s interim principal financial officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vineet Agarwal changed role as Chief Financial Officer at Korro Bio, Inc..

Action
taking a temporary medical leave of absence
Role
Chief Financial Officer
Exact text from the filing
Effective February 11, 2025, Vineet Agarwal, Chief Financial Officer (principal financial officer and principal accounting officer) of Korro Bio, Inc., or Korro, is taking a temporary medical leave of absence.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Oliver Dolan was appointed as Interim Principal Accounting Officer at Korro Bio, Inc..

Action
appointed
Role
Interim Principal Accounting Officer
Exact text from the filing
and Mr. Oliver Dolan, Senior Vice President, Finance, to serve as Korro’s interim principal accounting officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ram Aiyar was appointed as Interim Principal Financial Officer at Korro Bio, Inc..

Action
appointed
Role
Interim Principal Financial Officer
Exact text from the filing
Korro’s Board of Directors appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro’s interim principal financial officer
View on SEC.gov

Korro Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-024305
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.